As 2013 comes to a close, we find ourselves reflecting on the milestones of the past year. To better reflect the full spectrum of services we offer, our agency rebranded and adopted the name JPA [...]
Even with a significant decrease in prescription drug approvals in the United States, cancer patients stand to reap the benefits of many newly approved therapies. This year, a total of 98 new [...]
